211 related articles for article (PubMed ID: 32929098)
41. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
Linz D; Wirth K; Ukena C; Mahfoud F; Pöss J; Linz B; Böhm M; Neuberger HR
Heart Rhythm; 2013 Oct; 10(10):1525-30. PubMed ID: 23851058
[TBL] [Abstract][Full Text] [Related]
42. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.
van den Hoogenhof MMG; Beqqali A; Amin AS; van der Made I; Aufiero S; Khan MAF; Schumacher CA; Jansweijer JA; van Spaendonck-Zwarts KY; Remme CA; Backs J; Verkerk AO; Baartscheer A; Pinto YM; Creemers EE
Circulation; 2018 Sep; 138(13):1330-1342. PubMed ID: 29650543
[TBL] [Abstract][Full Text] [Related]
43. Chronic heart rate reduction facilitates cardiomyocyte survival after myocardial infarction.
Zhang RL; Christensen LP; Tomanek RJ
Anat Rec (Hoboken); 2010 May; 293(5):839-48. PubMed ID: 20225200
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of antiarrhythmic effect of metoprolol treatment after acute myocardial infarction: relationship between treatment responses and survival during a 3-year follow-up.
Olsson G; Rehnqvist N
Eur Heart J; 1986 Apr; 7(4):312-9. PubMed ID: 2424759
[TBL] [Abstract][Full Text] [Related]
45. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
Ptaszynski P; Kaczmarek K; Ruta J; Klingenheben T; Wranicz JK
Europace; 2013 Jan; 15(1):116-21. PubMed ID: 22772053
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Kochs M; Eggeling T; Hombach V
Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis.
Li J; Xu C; Liu Y; Li Y; Du S; Zhang R; Sun Y; Zhang R; Wang Y; Xue H; Ni S; Asiya M; Xue G; Li Y; Shi L; Li D; Pan Z; Zhang Y; Wang Z; Cai B; Wang N; Yang B
Basic Res Cardiol; 2020 Jan; 115(2):9. PubMed ID: 31900593
[TBL] [Abstract][Full Text] [Related]
48. Substrates and potential therapeutics of ventricular arrhythmias in heart failure.
Zhang D; Tu H; Wadman MC; Li YL
Eur J Pharmacol; 2018 Aug; 833():349-356. PubMed ID: 29940156
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Vaksmann G; Klug D
Pacing Clin Electrophysiol; 2018 Oct; 41(10):1378-1380. PubMed ID: 29989676
[TBL] [Abstract][Full Text] [Related]
50. Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group.
Am J Cardiol; 1985 Nov; 56(14):35G-38G. PubMed ID: 3904392
[TBL] [Abstract][Full Text] [Related]
51. Hyperpolarization-activated cyclic nucleotide-gated channel inhibitor in myocardial infarction: Potential benefits beyond heart rate modulation.
Sripusanapan A; Yanpiset P; Sriwichaiin S; Siri-Angkul N; Chattipakorn SC; Chattipakorn N
Acta Physiol (Oxf); 2024 Mar; 240(3):e14085. PubMed ID: 38230890
[TBL] [Abstract][Full Text] [Related]
52. Empiric therapy with beta-blockers.
Hjalmarson A
Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):460-6. PubMed ID: 7513874
[TBL] [Abstract][Full Text] [Related]
53. Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
Komori S; Sano S; Li BH; Matsumura K; Naitoh A; Mochizuki S; Ishihara T; Watanabe A; Umetani K; Ijiri H
Heart Vessels; 1995; 10(1):7-11. PubMed ID: 7537263
[TBL] [Abstract][Full Text] [Related]
54. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
Xu X; Guo Y; Gao W; Huang M; Liu T; Li F
Eur J Pediatr; 2023 May; 182(5):2265-2271. PubMed ID: 36869903
[TBL] [Abstract][Full Text] [Related]
55. Endurance exercise training normalizes repolarization and calcium-handling abnormalities, preventing ventricular fibrillation in a model of sudden cardiac death.
Bonilla IM; Belevych AE; Sridhar A; Nishijima Y; Ho HT; He Q; Kukielka M; Terentyev D; Terentyeva R; Liu B; Long VP; Györke S; Carnes CA; Billman GE
J Appl Physiol (1985); 2012 Dec; 113(11):1772-83. PubMed ID: 23042911
[TBL] [Abstract][Full Text] [Related]
56. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction.
Xing Y; Chen J; Wang J; Gao Y; Niu W; Zhao M; Zhu H; Guo L; Lu P; Wang S
J Ethnopharmacol; 2012 Jun; 141(2):674-84. PubMed ID: 21924334
[TBL] [Abstract][Full Text] [Related]
57. Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model.
Zhang H; Zhong H; Everett TH; Wilson E; Chang R; Zeng D; Belardinelli L; Olgin JE
Heart Rhythm; 2014 Jan; 11(1):101-9. PubMed ID: 24120874
[TBL] [Abstract][Full Text] [Related]
58. Heart failure as a substrate and trigger for ventricular tachycardia.
Alvarez CK; Cronin E; Baker WL; Kluger J
J Interv Card Electrophysiol; 2019 Dec; 56(3):229-247. PubMed ID: 31598875
[TBL] [Abstract][Full Text] [Related]
59. Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design.
Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Mangiameli S; Montenero A; Pedretti R; Salerno J; Sermasi S
Am J Cardiol; 1999 Mar; 83(5B):104D-111D. PubMed ID: 10089851
[TBL] [Abstract][Full Text] [Related]
60. Can antiarrhythmic drugs survive survival trials?
Pratt CM; Waldo AL; Camm AJ
Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
